この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Senthil M.に依頼
Australia
PhD Pharmaceutical Scientist | CMC & GMP Advisory | Vaccine Formulation | TGA Regulatory Readiness | Brisbane
プロフィール概要
専門分野
サービス
Writing
Non-Medical Regulatory Writing,
Technical Writing
Research
User Research,
Feasibility Study,
Gap Analysis
Consulting
Go-to-Market Strategy Consulting,
Healthcare Consulting,
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Processing,
Image Analysis
Product Development
Formulation,
Recipe Development,
Stability/Shelf Life Testing,
Product Evaluation,
Manufacturing,
Product Compliance ,
Concept Development,
Reverse Engineering
職務経験
Principal Consultant
Helion Advisory Group
8月 2025 - 現在
学歴
PhD
University of Groningen
11月 2009 - 5月 2014
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Patil, H.P., Murugappan, S., De Vries-Idema, J., Meijerhof, T., De Haan, A., Frijlink, H.W., Wilschut, J., Hinrichs, W.L.J., Huckriede, A.(2015). Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration . European Journal of Pharmaceutics and Biopharmaceutics. 93. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 231-241.
Murugappan, S., Frijlink, H.W., Petrovsky, N., Hinrichs, W.L.J.(2015). Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant . European Journal of Pharmaceutical Sciences. 66. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 118-122.
Patil, H.P., Murugappan, S., Ter Veer, W., Meijerhof, T., De Haan, A., Frijlink, H.W., Wilschut, J., Hinrichs, W.L.J., Huckriede, A.(2014). Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine . Journal of Controlled Release. 174. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 51-62.
Peeters, B., Tonnis, W.F., Murugappan, S., Rottier, P., Koch, G., Frijlink, H.W., Huckriede, A., Hinrichs, W.L.J.(2014). Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus . Vaccine. 32. (48). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 6445-6450.
Murugappan, S., Patil, H.P., Frijlink, H.W., Huckriede, A., Hinrichs, W.L.J.(2014). Simplifying influenza vaccination during pandemics: Sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine . AAPS Journal. 16. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 342-349.
Wahjudi, M., Murugappan, S., Van Merkerk, R., Eissens, A.C., Visser, M.R., Hinrichs, W.L.J., Quax, W.J.(2013). Development of a dry, stable and inhalable acyl-homoserine-lactone-acylase powder formulation for the treatment of pulmonary Pseudomonas aeruginosa infections . European Journal of Pharmaceutical Sciences. 48. (4-5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 637-643.
Murugappan, S., Patil, H.P., Kanojia, G., Ter Veer, W., Meijerhof, T., Frijlink, H.W., Huckriede, A., Hinrichs, W.L.J.(2013). Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants . European Journal of Pharmaceutics and Biopharmaceutics. 85. (3 PART A). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 716-725.